Home > Insider Trading > Filing (0001209191-16-095726)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401914	Cerulean Pharma Inc.	CERU	Pharmaceutical Preparations (2834)	204139823

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1205236	R David Walt	C/O Cerulean Pharma Inc. 35 Gatehouse Drive Waltham MA 02451		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-02-02	4,395	$2.37	116,998	No	4	P	Direct
Common Stock	Acquisiton	2016-02-03	4,018	$2.27	121,016	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

These purchases were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2015.
Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $2.26 to $2.475 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $2.23 to $2.30 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.